The WHO COVID-19 Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important. The latest version of this living guideline is available in pdf format (via the ‘Download’ […]
Read More
The worldwide popularity of coffee means that any research into health concerns or benefits is of widespread interest. New findings regarding potential protective effects and risks have once again resulted in the beverage becoming a top trending clinical topic. A new study in Kidney International Reports and material presented at this spring’s American College […]
Read More
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched a Phase 1 clinical trial evaluating three experimental HIV vaccines based on a messenger RNA (mRNA) platform—a technology used in several approved COVID-19 vaccines. NIAID is sponsoring the study, called HVTN 302, […]
Read More
Agroup of scientists who did more than perhaps any other to test new treatments for Covid, including establishing that the steroid dexamethasone can save lives, is now turning its focus to the rest of medicine. The first step, announced today: a partnership with the Paris-based drug giant, Sanofi. Sanofi will […]
Read More
Patients with SARS-CoV-2 infection can experience a range of clinical manifestations, from no symptoms to critical illness. This section of the Guidelines discusses the clinical presentation of SARS-CoV-2-infected individuals according to illness severity. In general, adults with SARS-CoV-2 infection can be grouped into the following severity of illness categories. However, […]
Read More
Abstract Background The COVID-19 pandemic has caused substantial morbidity and mortality. Objectives To describe monthly demographic and clinical trends among adults hospitalized with COVID-19. Design Pooled cross-sectional. Setting 99 counties within 14 states participating in the Coronavirus Disease 2019-Associated Hospitalization Surveillance Network (COVID-NET). Patients U.S. adults (aged ≥18 years) hospitalized with laboratory-confirmed COVID-19 during March […]
Read More
So far, the vaccines approved in the United States have been able to stand up to the most concerning SARS-CoV-2 mutations, but the fast-multiplying variants have investigators wondering whether a vaccine mix could help protect against unknown threats. Ross Kedl Combining different vaccine platforms — known as a heterologous prime-boost […]
Read More
A coronavirus vaccine that could be taken as a pill may enter clinical trials in the second quarter of 2021. The oral vaccine is being developed by Oravax Medical, a new joint venture of the Israeli-American company Oramed and the Indian company Premas Biotech, Business Insider reported. So far, all […]
Read More
Across the world, there are multiple variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19). SARS-CoV-2 variants have been classified by the Centers for Disease Control and Prevention (CDC) as variants of interest, variants of concern, and variants of high consequence. Three […]
Read More